Skip to main content

FDA could approve over-the-counter nasal spray, autoinjectors to treat opioid overdoses

But the FDA stressed that it needed more data to make a definitive conclusion on the use of the over-the-counter treatments for opioid overdoses.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.